Regulation and interactions in the activation of cell-associated plasminogen (Q35959550)

11 August 2017

1 reference

title

Regulation and interactions in the activation of cell-associated plasminogen (English)

1 reference

11 August 2017

Myöhänen H

1

1 reference

11 August 2017

Vaheri A

series ordinal

2

1 reference

11 August 2017

publication date

1 November 2004

1 reference

Cellular and Molecular Life Sciences

11 August 2017

published in

1 reference

11 August 2017

volume

61

1 reference

11 August 2017

issue

22

1 reference

11 August 2017

page(s)

2840-2858

1 reference

Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations.

11 August 2017

cites work

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Identification of a new intronic BMPR2-mutation and early diagnosis of heritable pulmonary arterial hypertension in a large family with mean clinical follow-up of 12 years

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

The combination of exercise and respiratory training improves respiratory muscle function in pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Addition of sildenafil to long-term intravenous epoprostenol therapy in patients with pulmonary arterial hypertension: a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Safety and efficacy of exercise training in various forms of pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Exercise training in pulmonary arterial hypertension associated with connective tissue diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Psychische Belastung und Psychosomatischer Behandlungswunsch von Patienten mit Pulmonaler Hypertonie

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Riociguat for the treatment of pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Genetics and genomics of pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Pulmonary endarterectomy: recent changes in a single institution's experience of more than 2,700 patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Effect of Exercise and Respiratory Training on Clinical Progression and Survival in Patients with Severe Chronic Pulmonary Hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Inhaled iloprost for severe pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Outcomes of noncardiac, nonobstetric surgery in patients with PAH: an international prospective survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Exercise capacity affects quality of life in patients with pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Ambulatory rehabilitation improves exercise capacity in patients with pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Exercise training for pulmonary hypertension: a systematic review and meta-analysis

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Effects of a rehabilitation program on skeletal muscle function in idiopathic pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Anxiety and depression in patients with pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Ablation of typical right atrial flutter in patients with pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Abnormal Pulmonary Artery Pressure Response in Asymptomatic Carriers of Primary Pulmonary Hypertension Gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

A retrospective study on the effects of pulmonary rehabilitation in patients with pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Pulmonary hypertension: Hemodynamic evaluation. Updated Recommendations of the Cologne Consensus Conference 2011.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Nocturnal oxygen therapy in patients with the Eisenmenger syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Long-term outcome with intravenous iloprost in pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Daytime measurements underestimate nocturnal oxygen desaturations in pulmonary arterial and chronic thromboembolic pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Therapie der pulmonal arteriellen Hypertonie (PAH)

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Rehabilitation program in adult congenital heart disease patients with pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Anxiety and depression disorders in patients with pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Efficacy of exercise training in pulmonary arterial hypertension associated with congenital heart disease.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Effect of aerobic exercise training on fatigue and physical activity in patients with pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Treatment of primary pulmonary hypertension with continuous intravenous prostacyclin (epoprostenol). Results of a randomized trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Upfront triple combination therapy in pulmonary arterial hypertension: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Pulmonary hypertension: hemodynamic evaluation: hemodynamic evaluation – recommendations of the Cologne Consensus Conference 2010

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

A role for combination therapy in pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Supportive therapy in pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Guidelines for the diagnosis and treatment of pulmonary hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Impact of pulmonary hypertension on the outcomes of noncardiac surgery: predictors of perioperative morbidity and mortality

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Surgical management and outcome of patients with chronic thromboembolic pulmonary hypertension: results from an international prospective registry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Selexipag: an oral, selective prostacyclin receptor agonist for the treatment of pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Exercise and Respiratory Training Improve Exercise Capacity and Quality of Life in Patients With Severe Chronic Pulmonary Hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

A meta-analysis of randomized controlled trials in pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Updated treatment algorithm of pulmonary arterial hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Incidence and clinical relevance of supraventricular tachyarrhythmias in pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Updated evidence-based treatment algorithm in pulmonary arterial hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Exercise training improves exercise capacity and quality of life in patients with inoperable or residual chronic thromboembolic pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Pregnancy outcomes in pulmonary arterial hypertension in the modern management era.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Benefits of intensive treadmill exercise training on cardiorespiratory function and quality of life in patients with pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Diagnosis and treatment of pulmonary artery hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Riociguat for the treatment of chronic thromboembolic pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Noncardiothoracic nonobstetric surgery in mild-to-moderate pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Effects of exercise training in patients with idiopathic pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Iron deficiency is common in idiopathic pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Economic evaluation of exercise training in patients with pulmonary hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Exercise improvement and plasma biomarker changes with intravenous treprostinil therapy for pulmonary arterial hypertension: a placebo-controlled trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Macitentan and morbidity and mortality in pulmonary arterial hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Elderly patients diagnosed with idiopathic pulmonary arterial hypertension: results from the COMPERA registry.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Position paper on the importance of psychosocial factors in cardiology: Update 2013

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Outcome after cardiopulmonary resuscitation in patients with pulmonary arterial hypertension.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

Exercise training in patients with pulmonary arterial hypertension: a case report

1 reference

https://pubmed.ncbi.nlm.nih.gov/15558213

12 December 2020

10.1007/S00018-004-4230-9

Identifiers

DOI

1 reference

11 August 2017

1 reference